Accendra Health
230 hedge funds and large institutions have $1.44B invested in Accendra Health in 2023 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 81 increasing their positions, 75 reducing their positions, and 29 closing their positions.
429% more call options, than puts
Call options by funds: $8.24M | Put options by funds: $1.56M
45% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 29
32% more capital invested
Capital invested by funds: $1.09B → $1.44B (+$350M)
6% more funds holding
Funds holding: 218 → 230 (+12)
1.42% more ownership
Funds ownership: 97.41% → 98.83% (+1.4%)
8% more repeat investments, than reductions
Existing positions increased: 81 | Existing positions reduced: 75
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$15.7M |
| 2 |
Nuveen
Charlotte,
North Carolina
|
+$8.78M |
| 3 |
D.E. Shaw & Co
New York
|
+$7.94M |
| 4 |
Goldman Sachs
New York
|
+$5.81M |
| 5 |
AG
Algert Global
San Francisco,
California
|
+$5.65M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$24.6M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$19M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$5.42M |
| 4 |
Janus Henderson Group
London,
|
-$4.61M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$3.96M |
ACH Hedge Fund Activity: Q2 2023 in Review
230 of the 6,373 institutional investors tracked by Wall St. Rank reported a position in Accendra Health (ACH) for Q2 2023, worth a combined $1.44B — up 32% from $1.09B a quarter earlier.
Buyers outnumbered sellers: 42 funds opened new ACH positions and 29 closed out — a net gain of 13 holders — while 81 added to existing stakes and 75 trimmed.
The largest buyer was Deerfield Management, adding an estimated $15.7M. The largest seller was Allspring Global Investments, cutting an estimated $24.6M.
- 230 institutional investors held Accendra Health (ACH) as of Q2 2023, up from 218 in Q1 2023.
- Funds reported $1.44B of Accendra Health stock for Q2 2023, up 32% quarter-over-quarter.
- 42 funds opened new Accendra Health positions in Q2 2023 and 29 closed out, a net change of +13 holders.
- The largest Accendra Health buyer in Q2 2023 was Deerfield Management, an estimated $15.7M added.
- The largest Accendra Health seller in Q2 2023 was Allspring Global Investments, an estimated $24.6M sold.
Based on aggregated 13F filings for Q2 2023.